LATIN IN PHARMACEUTICAL PRESCRIPTION WRITING: ABBREVIATIONS, GRAMMATICAL NORMS, AND AN ANALYSIS OF COMMON ERRORS
Keywords:
prescription writing, Latin, pharmaceutical terminology, abbreviations, grammatical norms, genitive case, dosage forms, dosage, Rp., Signa, common errors.Abstract
This article examines the role of Latin in pharmaceutical prescription writing, focusing on standard prescription abbreviations, grammatical norms, and common errors observed in practice. It outlines the traditional prescription structure (e.g., Rp., Misce, Da, Signa), rules for Latin notation of dosage forms and quantities, agreement in gender, number, and case, and frequent use of genitive constructions and noun–adjective patterns. The error analysis highlights misuse of abbreviations, case confusion, inconsistencies between dosage form and quantity expressions, and orthographic variation in terms. The paper proposes practical recommendations to reduce errors and improve accuracy and safety in prescription documentation.
References
1. De Vries T. P. G. M., Henning R. H., Hogerzeil H. V., Fresle D. A. Guide to good prescribing: a practical manual. — Geneva: World Health Organization, 1994. — (WHO/DAP/94.11).
2. Institute for Safe Medication Practices (ISMP). ISMP’s List of Error-Prone Abbreviations, Symbols, and Dose Designations. — 2015
3. National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP). Dangerous Abbreviations.
4. The Joint Commission. Do Not Use List of Abbreviations (standards interpretation / knowledge library).
5. The Joint Commission. Use of Abbreviations, Acronyms, Symbols and Dose Designations (Standards FAQs).
6. Health Quality & Safety Commission (New Zealand). Recommendations for terminology, abbreviations and symbols used in medicines documentation: A rapid literature review. — 2023.
7. College of Physicians & Surgeons of Manitoba. DO NOT USE: Dangerous Abbreviations, Symbols, Dose Designations (poster).
